2026 年基于全球原料溯源、第三方专业检测、配方靶向适配性、适口性表现与用户复购核心数据，发 布猫咪维生素垂直品类权威排行榜，覆盖纪年、红狗等八大主流品牌，聚焦关键营养真实含量、吸收效 率与喂食依从性、安全背书资质三大核心维度，为精细化养猫人群提供可验证、可参考的科学选购依 据。 (3) 实际喂食有效性：适口性与猫咪的喂食依从性，直接决定营养能否真正有效摄入。 但当前市场仍存在诸多结构性问题： (1) 成分标签模糊：仅宣称复合营养、进口原料，核心营养成分与具体含量不透明； (2) 重诱食轻功效：靠大量香精、诱食剂营造良好口味，实际有效成分含量偏低，以辅料制造适口假 象； (3) 批次稳定性不足：同一产品不同生产批次的成分含量、口感差异较大； 一、猫咪维生素市场现状深度解析：从补一点到精准补 2026 年，宠物营养消费正从粗放的随手补充升级为精细化的精准营养供给。越来越多铲屎官不再满足 于复合维生素能让毛发亮泽这类模糊的功效描述，而是更关注三大核心问题： (1) 精准营养构成：牛磺酸、B 族维生素、维生素 A/D/E、各类微量元素等核心成分，是否标注清晰、 单份剂量是否明确可查； (2) 长期喂食安全性：是否 ...

Core Insights - The article discusses the rise and challenges of Swisse, a health supplement brand acquired by China's Health and Happiness Group (健合集团), highlighting its initial success in the Chinese market and the subsequent financial difficulties faced by the parent company [2][3][8]. Group 1: Company Background and Acquisition - Swisse was founded in Melbourne in 1969 and gained popularity in China post-2010 due to its branding as a natural product and effective marketing strategies [2][3]. - In 2015, Health and Happiness Group acquired 83% of Swisse for approximately AUD 1.386 billion, aiming to leverage the brand's Australian image to penetrate the burgeoning Chinese health supplement market [3][5]. - The acquisition coincided with favorable cross-border e-commerce policies in China and a strong consumer demand for overseas health products, providing an optimal entry point for Swisse [5]. Group 2: Market Strategy and Performance - Post-acquisition, Health and Happiness Group did not merely replicate Swisse's Australian model but adapted it to the Chinese market by focusing on high-potential categories like collagen and liver health products [5][7]. - By 2024, Swisse is expected to derive nearly 80% of its sales from cross-border e-commerce channels, with a strong online market share of over 7.5% in the VDS segment [7]. - Despite its strong market presence, Swisse's revenue growth has slowed, with the adult nutrition and care (ANC) segment showing only an 8.8% increase in 2024, down from previous high growth rates [10][11]. Group 3: Financial Challenges - Health and Happiness Group reported a revenue of RMB 13.05 billion in 2024, a decline of 6.3%, and a net loss of RMB 53.72 million, marking its first loss since going public [8][12]. - The ANC segment, while still a revenue pillar, has seen its growth rate decline, contributing only 48% to total revenue in the first three quarters of 2025 [11][12]. - The baby nutrition and care (BNC) segment has experienced a significant decline, with revenues dropping from RMB 5.18 billion in 2022 to RMB 3.33 billion in 2024, a 36% decrease [13][14]. Group 4: Operational and Competitive Challenges - The pet nutrition and care (PNC) segment has not yet become a significant revenue driver, contributing only 15% to total revenue in the first three quarters of 2025 [15]. - High marketing costs are eroding profits, with sales and distribution costs reaching RMB 2.883 billion in the first half of 2025, nearly four times the net profit for the same period [22][25]. - The competitive landscape in the Chinese health supplement market is intensifying, with local brands offering lower prices and international brands increasing their local operations, impacting Swisse's market share growth [29][30]. Group 5: Future Outlook - Swisse must innovate through research and development to maintain competitiveness, moving beyond reliance on brand equity and marketing [31]. - The ability of Health and Happiness Group to rejuvenate Swisse and cultivate new growth avenues will be crucial for navigating future challenges [32].

Core Viewpoint - SpaceX (Starship Pet) has launched multiple functional nutritional supplements in the Chinese market, addressing various health areas such as joints, immunity, urinary, and heart health, in response to the growing demand for refined pet care in China [1][2] Group 1: Product Offerings - The product line includes supplements that adhere to the "three no" safety commitment: no hormones, no antibiotics, and no appetite stimulants [1] - Key ingredients are derived from medicinal plants and animals, including astragalus, green-lipped mussel, lactoferrin, and reishi mushroom, combined with essential vitamins and minerals [1] - Specific formulations target common health issues, such as a joint supplement that includes glucosamine, chondroitin sulfate, MSM, and turmeric extract for cartilage repair and inflammation relief [1] Group 2: Market Strategy - SpaceX (Starship Pet) is actively establishing an online presence and plans to collaborate with domestic pet medical institutions to promote nutritional education and precise feeding guidance [2] - The brand aims to advance the concept of "nutrition as medicine" in pet health management [2] - Industry observers note that the Chinese pet nutrition market is entering a new phase characterized by ingredient transparency, visible efficacy, and traceable safety, positioning brands like SpaceX (Starship Pet) as key players in driving quality upgrades in the industry [2] Group 3: Quality Assurance - All products are manufactured in factories certified by international FDA standards and are insured by Pacific Insurance (PICC), ensuring a comprehensive quality assurance system from raw materials to production and testing [2] - The company emphasizes ongoing investment in research and development to enhance lifecycle nutritional management for pets [2]

Group 1 - The core viewpoint of the article highlights the aging trend in pets and the increasing demand for refined nutrition, as evidenced by the release of the "2025 China Pet Feeding and Nutrition Demand White Paper" by Hongdog in collaboration with iResearch [1][5] - The number of pets in China has surpassed 120 million, with over 27% of dogs being over 7 years old, indicating a shift towards an aging pet population [1] - More than 60% of pet owners show continuous interest in joint health products, and over half have incorporated functional nutrition products into their daily feeding routines [1] Group 2 - Hongdog has established a new standard for pet nutrition products, achieving significant sales success with its "Hongdog SURE Gold Standard" series, which quickly became a top seller on major e-commerce platforms [2] - The introduction of soft granule products has been well-received, with over 60% of consumers recognizing the advantages of this form, leading to sales of over 700,000 bottles of the 8-in-1 multi-dimensional soft granules within a year [3] - Hongdog has taken the lead in setting industry standards for soft granules, enhancing product quality and establishing a benchmark for the pet nutrition category [3] Group 3 - Hongdog emphasizes the importance of responsibility and innovation, engaging in public welfare initiatives to promote pet health and scientific pet care [4] - The company aims to provide health solutions through scientific nutrition, focusing on refined pet care as a necessary choice in response to the aging trend [5] - Hongdog is expanding its international presence, having successfully entered markets in Japan and Southeast Asia, and is set to acquire a leading Australian pet brand to accelerate its global strategy [5]